Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Gordon

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
The Lancet. Global Health|June 28, 2025
The burden of multimorbidity-associated acute hospital admissions in Malawi and Tanzania: a prospective multicentre cohort studyStephen A Spencer, Nateiya M Yongolo, Ibrahim G Simiyu, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
The Journal of Clinical Investigation|June 1, 2022
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Clinical Investigation|July 31, 2019
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
The Journal of Infectious Diseases|July 10, 2024
Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge ModelBridgette Galafa, Tarsizio Chikaonda, Evaristar Kudowa, et al.
The Lancet. Respiratory Medicine|September 7, 2014
Respiratory risks from household air pollution in low and middle income countriesStephen B Gordon, Nigel G Bruce, Jonathan Grigg, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Nature|March 27, 2012
IFITM3 restricts the morbidity and mortality associated with influenzaAaron R Everitt, Simon Clare, Thomas Pertel, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
The Lancet. Global Health|June 28, 2025
The burden of multimorbidity-associated acute hospital admissions in Malawi and Tanzania: a prospective multicentre cohort studyStephen A Spencer, Nateiya M Yongolo, Ibrahim G Simiyu, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
The Journal of Clinical Investigation|June 1, 2022
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Clinical Investigation|July 31, 2019
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
The Journal of Infectious Diseases|July 10, 2024
Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge ModelBridgette Galafa, Tarsizio Chikaonda, Evaristar Kudowa, et al.
The Lancet. Respiratory Medicine|September 7, 2014
Respiratory risks from household air pollution in low and middle income countriesStephen B Gordon, Nigel G Bruce, Jonathan Grigg, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Nature|March 27, 2012
IFITM3 restricts the morbidity and mortality associated with influenzaAaron R Everitt, Simon Clare, Thomas Pertel, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Pageof 19